# A Randomised Trial Comparing Supraclavicular Block vs Supraclavicular and Pecs II Block in Arteriovenous Grafting

> **NCT02331030** · NA · COMPLETED · sponsor: **Changi General Hospital** · enrollment: 36 (actual)

## Conditions studied

- Arteriovenous Fistula
- Arteriovenous Graft
- Kidney Failure, Chronic
- Renal Failure, End-stage

## Interventions

- **PROCEDURE:** Supraclavicular
- **PROCEDURE:** Pecs II block
- **PROCEDURE:** Sham block (Grade 1)
- **DRUG:** Ropivacaine 0.5% 20ml
- **DRUG:** Ropivacaine 0.5% 10ml

## Key facts

- **NCT ID:** NCT02331030
- **Lead sponsor:** Changi General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-12
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2017-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02331030

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02331030, "A Randomised Trial Comparing Supraclavicular Block vs Supraclavicular and Pecs II Block in Arteriovenous Grafting". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02331030. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*